Author Information
Guy Boivin is a prominent researcher affiliated with the Research Center in Infectious Diseases at CHU de Québec and Laval University, located in Quebec City, Quebec, Canada. His work is primarily focused on infectious diseases, with a significant emphasis on virology and immunology. His research contributes to a deeper understanding of infectious disease mechanisms and potential therapeutic approaches.Research Contributions
Guy Boivin has made substantial contributions to the field of infectious diseases through his extensive research on various viral infections, including COVID-19, influenza, and respiratory syncytial virus (RSV). In 2022, his work addressed critical topics like COVID-19 reinfection risks, the impacts of isolation and treatment on contagiousness, and the immunogenicity of COVID-19 vaccines. His studies on viral interference, such as between influenza A(H1N1)pdm09 virus and SARS-CoV-2, provide valuable insights into viral behavior and interactions. Additionally, his research includes evaluating the hospitalization risk factors for COVID-19 patients and investigating the resistance barriers of antiviral drugs like Remdesivir.Aliases
Guy Boivin is also known by other variations of his name in academic publications, including G Boivin and G. Boivin. These aliases are used interchangeably in his published works.Publication and Citation Metrics
| Metric |
Count |
| Total Citation Count |
26,654 |
| H-index |
87 |
| Total Paper Count |
662 |
